<DOC>
	<DOC>NCT02347046</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety after single oral administration of FYU-981 to subjects with renal insufficiency and with normal renal function.</brief_summary>
	<brief_title>Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Japanese adult subjects Body mass index: &gt;=18.5 and &lt;30.0 Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>